Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma.

Saved in:
Bibliographic Details
Title: Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma.
Authors: Watchmaker PB; Department of Neurosurgery, University of California, San Francisco., Colton M; Department of Neurosurgery, University of California, San Francisco., Pineo-Cavanaugh PL; Department of Neurosurgery, University of California, San Francisco., Okada H; Department of Neurosurgery, University of California, San Francisco.; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
Source: Current opinion in oncology [Curr Opin Oncol] 2022 Nov 01; Vol. 34 (6), pp. 661-669. Date of Electronic Publication: 2022 Jul 19.
Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9007265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-703X (Electronic) Linking ISSN: 10408746 NLM ISO Abbreviation: Curr Opin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1531-703X
DOI:10.1097/CCO.0000000000000877